The impact of hepatitis B virus x protein and microRNAs in hepatocellular carcinoma: a comprehensive analysis

Tumor Biology

Volumn 35, Issue 12, 2014, Pages 11695-11700

  Lin, Li ^a   Yin, Xiaomao ^a   Hu, Xiumei ^a   Wang, Qian ^a   Zheng, Lei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B virus infection; Hepatitis B virus x protein; Hepatocellular carcinoma; microRNAs

Indexed keywords

DNA METHYLTRANSFERASE; HEPATITIS B VIRUS X PROTEIN; MICRORNA; MICRORNA 122; MICRORNA 205; MICRORNA 21; MICRORNA 29A; MICRORNA 29C; MICRORNA 375; MICRORNA LET7A; UNCLASSIFIED DRUG; TRANSACTIVATOR PROTEIN;

APOPTOSIS; CELL PROLIFERATION; DNA METHYLATION; GENE EXPRESSION REGULATION; HEPATITIS B; HEPATOMA CELL; HUMAN; LIPID METABOLISM; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR DIFFERENTIATION; TUMOR INVASION; VIRUS CARCINOGENESIS; ANIMAL; CARCINOMA, HEPATOCELLULAR; COMPLICATION; GENETICS; HEPATITIS B VIRUS; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIROLOGY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MICRORNAS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84925284579     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2658-6     Document Type: Review

References (55)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Kew MC. Epidemiology of chronic hepatitis b virus infection, hepatocellular carcinoma, and hepatitis b virus-induced hepatocellular carcinoma. Pathol Biol. 2010;58:273–7.
3. Zhang X, Zhang H, Ye L. Effects of hepatitis b virus x protein on the development of liver cancer. J Lab Clin Med. 2006;147:58–66.
4. Paterlini P, Poussin K, Kew M, Franco D, Brechot C. Selective accumulation of the x transcript of hepatitis b virus in patients negative for hepatitis b surface antigen with hepatocellular carcinoma. Hepatology (Baltimore, Md). 1995;21:313–21.
5. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–54.
6. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science (New York, NY). 2001;294:862–4.
7. Ambros V, Lee RC, Lavanway A, Williams PT, Jewell D. MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr Biol: CB. 2003;13:807–18.
8. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101:2999–3004.
9. Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science (New York, NY). 2005;309:1519–24.
10. He L, Hannon GJ. MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522–31.
11. Cuperus JT, Fahlgren N, Carrington JC. Evolution and functional diversification of miRNA genes. Plant Cell. 2011;23:431–42.
12. Lytle JR, Yario TA, Steitz JA. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' utr as in the 3' utr. Proc Natl Acad Sci U S A. 2007;104:9667–72.
13. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. Mirbase: MicroRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34:D140–4.
14. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 2006;25:2537–45.
15. Jiang R, Deng L, Zhao L, Li X, Zhang F, Xia Y, et al. Mir-22 promotes hbv-related hepatocellular carcinoma development in males. Clin Cancer Res: Off J Am Assoc Cancer Res. 2011;17:5593–603.
16. Dang Y, Luo D, Rong M, Chen G. Underexpression of mir-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-met. PLoS One. 2013;8:e61054.
17. Wu XJ, Li Y, Liu D, Zhao LD, Bai B, Xue MH. Mir-27a as an oncogenic microRNA of hepatitis b virus- related hepatocellular carcinoma. Asian Pac J Cancer Prev: APJCP. 2013;14:885–9.
18. Fan CG, Wang CM, Tian C, Wang Y, Li L, Sun WS, et al. Mir-122 inhibits viral replication and cell proliferation in hepatitis b virus-related hepatocellular carcinoma and targets ndrg3. Oncol Rep. 2011;26:1281–6.
19. Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, Ning S, et al. Tgf-beta-mir-34a-ccl22 signaling-induced treg cell recruitment promotes venous metastases of hbv-positive hepatocellular carcinoma. Cancer Cell. 2012;22:291–303.
20. Klein R, Schroder CH, Zentgraf H. Expression of the x protein of hepatitis b virus in insect cells using recombinant baculoviruses. Virus Genes. 1991;5:157–74.
21. Schek N, Bartenschlager R, Kuhn C, Schaller H. Phosphorylation and rapid turnover of hepatitis b virus x-protein expressed in hepg2 cells from a recombinant vaccinia virus. Oncogene. 1991;6:1735–44.
22. Spandau DF, Wang HG, Fraser MJ, Lee CH. A functional hepatitis b virus x protein produced in insect cells. Virology. 1991;185:938–41.
23. Gong P, Zhang X, Zhang J, Zhang J, Luo H, Wang Z. Hepatitis b virus x protein in the proliferation of hepatocellular carcinoma cells. Front Biosci (Landmark edition). 2013;18:1256–65.
24. Cha MY, Kim CM, Park YM, Ryu WS. Hepatitis b virus x protein is essential for the activation of wnt/beta-catenin signaling in hepatoma cells. Hepatology (Baltimore, Md). 2004;39:1683–93.
25. Yun C, Cho H, Kim SJ, Lee JH, Park SY, Chan GK, et al. Mitotic aberration coupled with centrosome amplification is induced by hepatitis b virus x oncoprotein via the ras-mitogen-activated protein/extracellular signal-regulated kinase-mitogen-activated protein pathway. Mol Cancer Res: MCR. 2004;2:159–69.
26. Lu JW, Yang WY, Tsai SM, Lin YM, Chang PH, Chen JR, et al. Liver-specific expressions of hbx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish. PLoS One. 2013;8:e76951.
27. Kordestani R, Mirshafiee H, Hosseini SM, Sharifi Z. Effect of hepatitis b virus x gene on the expression level of p53 gene using hep g2 cell line. Avicenna J Med Biotechnol. 2014;6:3–9.
28. Capovilla A, Carmona S, Arbuthnot P. Hepatitis b virus x-protein binds damaged DNA and sensitizes liver cells to ultraviolet irradiation. Biochem Biophys Res Commun. 1997;232:255–60.
29. Gearhart TL, Bouchard MJ. The hepatitis b virus x protein modulates hepatocyte proliferation pathways to stimulate viral replication. J Virol. 2010;84:2675–86.
30. Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB, et al. Hepatitis b virus x protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microrna-21 expression. Eur J Cancer (Oxford, England: 1990). 2014.
31. Tong A, Gou L, Lau QC, Chen B, Zhao X, Li J, et al. Proteomic profiling identifies aberrant epigenetic modifications induced by hepatitis b virus x protein. J Proteome Res. 2009;8:1037–46.
32. Girault I, Tozlu S, Lidereau R, Bieche I. Expression analysis of DNA methyltransferases 1, 3a, and 3b in sporadic breast carcinomas. Clin Cancer Res: Off J Am Assoc Cancer Res. 2003;9:4415–22.
33. Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X, et al. Mir-101 is down-regulated by the hepatitis b virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3a. Cell Signal. 2013;25:439–46.
34. Huang J, Wang Y, Guo Y, Sun S. Down-regulated microrna-152 induces aberrant DNA methylation in hepatitis b virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology (Baltimore, Md). 2010;52:60–70.
35. Zhang T, Zhang J, Cui M, Liu F, You X, Du Y, et al. Hepatitis b virus x protein inhibits tumor suppressor mir-205 through inducing hypermethylation of mir-205 promoter to enhance carcinogenesis. Neoplasia (New York, NY). 2013;15:1282–91.
36. Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, et al. Epigenetic repression of mir-132 expression by the hepatitis b virus x protein in hepatitis b virus-related hepatocellular carcinoma. Cell Signal. 2013;25:1037–43.
37. Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle (Georgetown, Tex). 2007;6:2127–32.
38. Wang CM, Wang Y, Fan CG, Xu FF, Sun WS, Liu YG, et al. Mir-29c targets tnfaip3, inhibits cell proliferation and induces apoptosis in hepatitis b virus-related hepatocellular carcinoma. Biochem Biophys Res Commun. 2011;411:586–92.
39. Zhu XM, Wu LJ, Xu J, Yang R, Wu FS. Let-7c microRNA expression and clinical significance in hepatocellular carcinoma. J Int Med Res. 2011;39:2323–9.
40. Meng F, Henson R, Wehbe-Janek H, Smith H, Ueno Y, Patel T. The microrna let-7a modulates interleukin-6-dependent stat-3 survival signaling in malignant human cholangiocytes. J Biol Chem. 2007;282:8256–64.
41. Cao Q, Li YY, He WF, Zhang ZZ, Zhou Q, Liu X, et al. Interplay between microRNAs and the stat3 signaling pathway in human cancers. Physiol Genomics. 2013;45:1206–14.
42. Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, et al. Lethal-7 is down-regulated by the hepatitis b virus x protein and targets signal transducer and activator of transcription 3. J Hepatol. 2010;53:57–66.
43. Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, et al. Hepatitis b virus x protein downregulates expression of the mir-16 family in malignant hepatocytes in vitro. Br J Cancer. 2011;105:146–53.
44. Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC, Wu CY, et al. Downregulation of microRNA-15b by hepatitis b virus x enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced globo h expression. Int J Cancer J Int Cancer. 2014;134:1638–47.
45. Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT. Identification of deregulated miRNAs and their targets in hepatitis b virus-associated hepatocellular carcinoma. World J Gastroenterol: WJG. 2012;18:5442–53.
46. Yuan K, Lian Z, Sun B, Clayton MM, Ng IO, Feitelson MA. Role of mir-148a in hepatitis b associated hepatocellular carcinoma. PLoS One. 2012;7:e35331.
47. Gailhouste L, Gomez-Santos L, Hagiwara K, Hatada I, Kitagawa N, Kawaharada K, et al. Mir-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells. Hepatology (Baltimore, Md). 2013;58:1153–65.
48. Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, et al. Hepatitis b virus x protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest. 2013;123:630–45.
49. Zhang X, Liu S, Hu T, Liu S, He Y, Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa b enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology (Baltimore, Md). 2009;50:490–9.
50. Kong G, Zhang J, Zhang S, Shan C, Ye L, Zhang X. Upregulated microrna-29a by hepatitis b virus x protein enhances hepatoma cell migration by targeting pten in cell culture model. PLoS One. 2011;6:e19518.
51. Zhao J, Wang W, Huang Y, Wu J, Chen M, Cui P, et al. Hbx elevates oncoprotein aeg-1 expression to promote cell migration by downregulating mir-375 and mir-136 in malignant hepatocytes. DNA Cell Biol. 2014.
52. Cui M, Xiao Z, Sun B, Wang Y, Zheng M, Ye L, et al. Involvement of cholesterol in hepatitis b virus x protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating mir-205-targeted acsl4. Biochem Biophys Res Commun. 2014;445:651–5.
53. Cui M, Wang Y, Sun B, Xiao Z, Ye L, Zhang X. Mir-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-coa synthetase long-chain family member 1 (acsl1) mRNA. Biochem Biophys Res Commun. 2014;444:270–5.
54. Liu F, You X, Chi X, Wang T, Ye L, Niu J, et al. Hepatitis b virus x protein mutant hbxdelta127 promotes proliferation of hepatoma cells through up-regulating mir-215 targeting ptprt. Biochem Biophys Res Commun. 2014;444:128–34.
55. Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, et al. Biological impact of natural cooh-terminal deletions of hepatitis b virus x protein in hepatocellular carcinoma tissues. Cancer Res. 2001;61:7803–10.